Events in the Series
World RNA Conference Calendar
RNA-based medicines have taken the spotlight in recent years and, following countless investments and collaborations, we have seen tremendous breakthroughs in development of RNA-based and RNA-targeting therapeutics and vaccines.
The World RNA Series presents a comprehensive portfolio of niche, industry-focused meetings, providing unrivaled knowledge-sharing and networking opportunities to help deliver safe and effective RNA and mRNA therapeutics and vaccines to patients faster.
View the World RNA Series conference calendar below. If you have any questions, get in touch at firstname.lastname@example.org.
Advance Your mRNA Pipelines to Front-Line Treatments by Successfully Translating Proof-of-Concepts with Safety, Efficacy & Regulatory Approval
Streamlining Purification, Yield & Scalability of Plasmid & Enzymatic DNA to Harmonize with Regulatory Expectations & Meet Increasing Global Demand for High Quality Therapeutics & Effective Vaccines
Enhance Speed, Purity, Flexibility & Scalability of Your Process Development & Manufacturing to Improve Functionality, Efficacy & Approval Rate of mRNA Drugs Across All Disease Indications
Fast-Tracking mRNA Therapeutics & Vaccines from Discovery to Commercialization Through Targeted Delivery, Safety & Tolerability to Achieve Clinical Success & Regulatory Harmonization Across All Disease Indications
Accelerating mRNA Process Development & Manufacturing from Research to Commercial Scale with Increased Efficiency, Stability & Therapeutic Applicability for Regulatory & Market Readiness
Developing Sensitive & Robust Bioanalytical, Analytical & Potency Assays to Accurately Measure Quality, Expression & Efficacy for
Accelerated mRNA Drug Development
Exposing the Latest Chemical & Pharmaceutical Advancements in RNAi Drug Discovery & Development Through Unlocking Novel Targets, Advancing Extra-Hepatic Delivery & Optimizing Chemical Modifications to Ensure Specific & Efficient Delivery to Target Tissues Across Organs & Diseases
Stay Ahead of the Curve with Novel RNA Therapeutics that Offer Exceptional Stability & Durability Whilst Addressing Key Delivery, Pharmacology & Scalability Challenges to Successfully Translate Safe & Effective Next Generation RNA Therapeutics into the Clinic
Unlock Native & Engineered Exosomes with Improved Targeting, Optimize Analytics & Achieve GMP Manufacturing for Effective Translation into the Clinic & Towards Commercialization